- Home
- CNSP vs LRHC Comparison
CNSP vs LRHC Comparison
Compare CNSP & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- LRHC
- Stock Information
- Founded
- CNSP 2017
- LRHC 2004
- Country
- CNSP United States
- LRHC United States
- Employees
- CNSP N/A
- LRHC N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- LRHC
- Sector
- CNSP Health Care
- LRHC
- Exchange
- CNSP Nasdaq
- LRHC Nasdaq
- Market Cap
- CNSP 5.6M
- LRHC 5.6M
- IPO Year
- CNSP 2019
- LRHC 2023
- Fundamental
- Price
- CNSP $8.82
- LRHC $7.66
- Analyst Decision
- CNSP Hold
- LRHC
- Analyst Count
- CNSP 1
- LRHC 0
- Target Price
- CNSP N/A
- LRHC N/A
- AVG Volume (30 Days)
- CNSP 27.0K
- LRHC 550.0K
- Earning Date
- CNSP 08-13-2025
- LRHC 08-14-2025
- Dividend Yield
- CNSP N/A
- LRHC N/A
- EPS Growth
- CNSP N/A
- LRHC N/A
- EPS
- CNSP N/A
- LRHC N/A
- Revenue
- CNSP N/A
- LRHC $73,874,281.00
- Revenue This Year
- CNSP N/A
- LRHC N/A
- Revenue Next Year
- CNSP N/A
- LRHC N/A
- P/E Ratio
- CNSP N/A
- LRHC N/A
- Revenue Growth
- CNSP N/A
- LRHC 90.36
- 52 Week Low
- CNSP $7.72
- LRHC $6.40
- 52 Week High
- CNSP $744.00
- LRHC $142.40
- Technical
- Relative Strength Index (RSI)
- CNSP 37.72
- LRHC 42.97
- Support Level
- CNSP $7.72
- LRHC $7.25
- Resistance Level
- CNSP $9.62
- LRHC $8.90
- Average True Range (ATR)
- CNSP 0.86
- LRHC 0.75
- MACD
- CNSP -0.13
- LRHC 0.08
- Stochastic Oscillator
- CNSP 29.99
- LRHC 37.86
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.